Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Regeneron Pharmaceuticals Inc. buy RudolfL

Regeneron Pharmaceuticals Inc.
Start price
€485.05
23.11.20 / 60%
Target price
€770.00
07.07.23
Performance (%)
39.47%
End price
€676.50
25.05.23
Summary
This prediction ended on 25.05.23 with a price of €676.50. The BUY prediction by RudolfL for Regeneron Pharmaceuticals Inc. saw massive gains of 39.47%. RudolfL has 60% into this prediction

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Performance without dividends (%)
Name 1w 1m 1y 3y
Regeneron Pharmaceuticals Inc. 0.689% 0.689% 16.349% 110.010%
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to RudolfL what are the pros and cons of Regeneron Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
positive Cash Flow expected
Cons

Comments by RudolfL for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 39.47%
Target price 520.000
Change
Ends at

Buy mit Kursziel 520,0

RudolfL 
0
Report Share
23.11.20
Prediction Buy
Perf. (%) 39.47%
Target price 600.000
Change
Ends at 23.11.21

Kursziel geändert auf 600,0

RudolfL 
0
Report Share
31.08.21
Prediction Buy
Perf. (%) 39.47%
Target price 680.000
Change
Ends at 27.10.22

Kursziel geändert auf 680,0

RudolfL 
0
Report Share
27.04.22
Prediction Buy
Perf. (%) 39.47%
Target price 770.000
Change
Ends at 27.10.22

Kursziel geändert auf 770,0

RudolfL 
0
Report Share
08.09.22
In the thread Trading Regeneron Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 39.47%
Target price 770.000
Change
Ends at 07.07.23

Buy beendet

RudolfL 
0
Report Share
25.05.23

Stopped prediction by RudolfL for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€400.05
22.03.20
-
26.05.20
21.98%
26.05.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
RudolfL 
22.03.20 50%